CoChat

The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer

Open access
Ozel, Irem, Duerig, Inga, Domnich, Maksim, Lang, Stephan, Pylaeva, Ekaterina, Jablonska, Jadwiga · 2022 · Cancers
Cited by 86

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Angiogenesis, the formation of new blood vessels from already existing vasculature, is tightly regulated by pro- and anti-angiogenic stimuli and occurs under both physiological and pathological conditions. Tumor angiogenesis is central for tumor development, and an “angiogenic switch” could be initiated by multiple immune cells, such as neutrophils. Tumor-associated neutrophils promote tumor angiogenesis by the release of both conventional and non-conventional pro-angiogenic factors. Therefore, neutrophil-mediated tumor angiogenesis should be taken into consideration in the design of novel anti-cancer therapy. This review recapitulates the complex role of neutrophils in tumor angiogenesis and summarizes neutrophil-derived pro-angiogenic factors and mechanisms regulating angiogenic activity of tumor-associated neutrophils. Moreover, it provides up-to-date information about neutrophil-targeting therapy, complementary to anti-angiogenic treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14030536

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 86

Metadata

Authors
Ozel, I., Duerig, I., Domnich, M., Lang, S., Pylaeva, E., & Jablonska, J.
Venue
Cancers
Publisher
MDPI AG
Published
2022-01-21
Volume
14
Issue
3
Pages
536
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4207002960
Cited by
86
References
15
FWCI
4.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. https://app.cochat.ai/papers/10.3390/cancers14030536
The paper
Ozel, I., Duerig, I., Domnich, M., Lang, S., Pylaeva, E., & Jablonska, J. (2022). The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. Cancers. https://doi.org/10.3390/cancers14030536

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.